- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | Mallinckrodt and Endo sign $6.7bn merger deal | ||
| 13.03. | Vivani treats first patient with long-lasting drug implant for weight loss | ||
| 13.03. | Emergent signs financial investment agreement with Swiss Rockets | ||
| 13.03. | Telix's new lead-212 generator could dispel medical isotope scalability hurdles | ||
| 13.03. | Vivace closes $35m in Series D for cancer drug development | ||
| 13.03. | Atsena's ATSN-201 gains FDA fast track status for XLRS treatment | ||
| 12.03. | Ono earmarks $940m to gain rare blood cancer therapy from Ionis | ||
| 12.03. | Envirotainer expands cold chain solutions portfolio to cover all pharma segments, sizes and temperatures | ||
| 12.03. | Vori Health secures $53m funding to support musculoskeletal care | ||
| 12.03. | Zealand Pharma and Roche strike $5.3bn obesity treatment deal | ||
| 12.03. | Canada and Alberta governments to invest in Entos R&D facility | ||
| 12.03. | WuXi XDC and AbTis collaborate on antibody-drug conjugates | ||
| 11.03. | Viking strikes $150m deal to secure supply of obesity drug | ||
| 11.03. | MSD expands vaccine production with new $1bn facility | ||
| 11.03. | Lundbeck's amlenetug gains orphan drug status in Japan for MSA | ||
| 11.03. | ElevateBio taps Amazon's genAI tools to design CRISPR therapeutics | ||
| 11.03. | Amid deglobalising trade, experts seek AI safeguards for clinical trial supply | ||
| 11.03. | Kenox and Lactiga partner on sIgA therapies for immunodeficiency | ||
| 10.03. | Vaccinex plans Nasdaq exit as Alzheimer market pressure grows | ||
| 10.03. | Artificial intelligence is making clinical supply chains more efficient and more sustainable: here's how | ||
| 10.03. | IA-2A positivity identified as a key predictor in type 1 diabetes progression | ||
| 10.03. | Roche announces hub for cardiovascular, renal and metabolism research | ||
| 10.03. | Alliance Pharma agrees to £362m acquisition by DBAY | ||
| 10.03. | EC approves BMS' Opdivo and Yervoy combo for HCC | ||
| 10.03. | Sun Pharma agrees to acquire Checkpoint Therapeutics |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
